Elsevier

Chemical Engineering Science

Volume 61, Issue 3, February 2006, Pages 1027-1040
Chemical Engineering Science

Inorganic nanoparticles as carriers for efficient cellular delivery

https://doi.org/10.1016/j.ces.2005.06.019Get rights and content

Abstract

Cellular delivery involving the transfer of various drugs and bio-active molecules (peptides, proteins and DNAs, etc.) through the cell membrane into cells has attracted increasing attention because of its importance in medicine and drug delivery. This topic has been extensively reviewed. The direct delivery of drugs and biomolecules, however, is generally inefficient and suffering from problems such as enzymic degradation of DNAs. Therefore, searching for efficient and safe transport vehicles (carriers) to delivery genes or drugs into cells has been challenging yet exciting area of research. In past decades, many carriers have been developed and investigated extensively which can be generally classified into four major groups: viral carriers, organic cationic compounds, recombinant protiens and inorganic nanoparticles. Many inorganic materials, such as calcium phosphate, gold, carbon materials, silicon oxide, iron oxide and layered double hydroxide (LDH), have been studied. Inorganic nanoparticles show low toxicity and promise for controlled delivery properties, thus presenting a new alternative to viral carriers and cationic carriers. Inorganic nanoparticles generally possess versatile properties suitable for cellular delivery, including wide availability, rich functionality, good biocompatibility, potential capability of targeted delivery (e.g. selectively destroying cancer cells but sparing normal tissues) and controlled release of carried drugs. This paper reviews the latest advances in inorganic nanoparticle applications as cellular delivery carriers and highlights some key issues in efficient cellular delivery using inorganic nanoparticles. Critical properties of inorganic nanoparticles, surface functionalisation (modification), uptake of biomolecules, the driving forces for delivery, and release of biomolecules will be reviewed systematically. Selected examples of promising inorganic nanoparticle delivery systems, including gold, fullerences and carbon nanotubes, LDH and various oxide nanoparticles in particular their applications for gene delivery will be discussed. The fundamental understanding of properties of inorganic nanoparticles in relation to cellular delivery efficiency as the most paramount issue will be highlighted.

Introduction

Cellular delivery involving the transfer of various drugs and bio-active molecules (peptides, proteins and DNAs, etc.) through the cell membrane into cells has attracted increasing attention because of its importance in medicine and drug delivery. This topic has been extensively reviewed (Heiser, 2004, Azzam and Domb, 2004, Dietz and Bahr, 2004, Langer and Peppas, 2003, Rolland, 1999, Garnett, 2004). The direct delivery of drugs and biomolecules, however, is generally inefficient and suffers from problems such as enzymic degradation of DNAs (Heiser, 2004, Garnett, 2004). Therefore, searching for efficient and safe transport vehicles (carriers) to delivery biomolecules and drugs into cells has been challenging yet exciting area of research. Virus is an excellent example in nature that transfers into the targeted cells very efficiently. It is also known for a long time that polybasic peptides like poly(lysine) highly enhance the protein uptake, and based on these, an omnipotent and marvelous carrier, i.e., Trojan Horse was designed which can carry the desired drugs, proteins or DNAs cross the cell membrane efficiently (Dietz and Bahr, 2004).

In past decades, many carriers have been developed and investigated extensively (Azzam and Domb, 2004, Garnett, 2004), and can be generally classified into four major groups: viral carriers, organic cationic compounds, recombinant proteins and inorganic nanoparticles. In viral carriers, part of original gene segment is eliminated to leave space for the gene to be inserted and delivered. Carriers consisting of cationic compounds mainly include cationic lipids, cationic polysaccharides, polycationic polymers, where the positive charges are resulted from protonation of various amino/imino groups. A particular type of DNA vectors receiving attention recently is recombinant proteins (Aris and Villlaverde, 2004). These proteins mimic the various viral properties by combining diverse peptide segments that are required for efficient gene delivery into a single molecule through protein engineering. For example, the multifunctional proteins may include polylysine segments, protamine, histones and amphipathic cationic peptides to bind DNA to form thermodynamically stable complexes. They may also contain antibodies, antibody segments for targeting cell delivery and some short peptide sequences acting as nuclear localisation signals. Although the formation of vector-DNA complexes is similar to the normal cationic compounds, protein vectors are much more biocompatible. Inorganic nanoparticles as new non-viral carriers have attracted much attention only recently. Many inorganic materials, such as calcium phosphate, gold, carbon materials, silicon oxide, iron oxide and layered double hydroxide (LDH), have been studied. The four types of carriers are briefly compared in Table 1. In summary, viral carriers are to date the most effective, but severe side effects (e.g. immune response and insertional mutagenesis) limit the successful application in cellular delivery. Cationic carriers (lipids and polymers) may avoid such problems but are often toxic to the cells. In contrast, inorganic nanoparticles show low toxicity and promise for controlled delivery properties, thus presenting a new alternative to viral carriers and cationic carriers. However, it is noted that the cellular transfer efficiency with existing inorganic nanoparticles is relatively low at this stage.

Inorganic nanoparticles generally possess versatile properties suitable for cellular delivery, including wide availability, rich functionality, good biocompatibility, potential capability of targeted delivery (e.g. selectively destroying cancer cells but sparing normal tissues) and controlled release of carried drugs. This is why increasing efforts in research and development worldwide have been devoted to various inorganic materials as novel non-viral carriers in the last decade (Ozkan, 2004, Barbe et al., 2004, Bauer et al., 2004). The present review aims to examine the latest advances in inorganic nanoparticle applications as cellular delivery carriers and highlight some of the key issues in efficient cellular delivery using inorganic nanoparticles. Critical properties of inorganic nanoparticles, surface functionalisation (modification), uptake of biomolecules, the driving forces for delivery, and release of biomolecules will be reviewed systematically in Section 2. Section 3 will present selected examples of promising inorganic nanoparticle delivery systems, including gold, fullerenes and carbon nanotubes (CNTs), LDH and various oxide nanoparticles in particular their applications for gene delivery. The fundamental understanding of properties of inorganic nanoparticles in relation to cellular delivery efficiency is the most paramount issue which will be highlighted in Section 4.

To avoid possible confusion in some terminologies, we present the following basic definitions and terminologies for the convenience of the readers. Nanoparticles generally refer to particles with diameters ranging from 1 to a few 100 nm. Functionalised inorganic nanoparticles with or without biomolecules loaded are generally described as hybrid nanoparticles, organic/inorganic nanohybrids or simply nanohybrids. In addition, carriers, vectors and agents in the content of this paper all refer to the vehicles that are used to carry drugs and biomolecules for cellular delivery.

Section snippets

Properties and bio-interactions of inorganic nanoparticles

To aid our understanding of the fundamental surface properties, and functionalisation of nanoparticles and their bio-interactions, it is useful to conceptualise some generic scenarios of nanoparticles and biomolecular interactions. Fig. 1 is a schematic representation of surface-functionalised inorganic nanoparticles (also refer to Table 2), and the processes of biomolecule uptake and the cellular transfer pathways. The critical factors that affect the transfection efficiency and effectiveness

Gold and other metal nanoparticles

Metal nanoparticles (including nanospheres, nanoshells and nanorods) have been evaluated for target cellular delivery. Gold nanoparticles in particular are an excellent intracellular targeting vector because: (1) they can be easily tailored to a desirable size from 0.8 and 200 nm; (2) their surface can be modified to impart various functionalities and good biocompatibility; (3) they possess visible light extinction behaviour, which makes it possible to track nanoparticle trajectories in the

Availability and particle size

All of the inorganic nanoparticles discussed in the previous sections are either commercialised or can be readily prepared in laboratory. For example, silica suspensions and fullerenes are available from various chemical companies. LDH and iron magnetic nanoparticles can be readily synthesised with a well controlled particle size. As mentioned previously, the size of inorganic nanoparticles can range from 1 to 200 nm (Table 2). After appropriate modifications, the size of hybrid nanoparticles

Concluding remarks and perspectives

There have been an increasing number of inorganic nanoparticles that have been studied as drug (gene) delivery carriers, because of their versatile physicochemical properties. Inorganic nanoparticles are readily available, can be easily functionalised, and possess good biocompatibility and low cytotoxicity, as summarised in Table 2. It is evident that the versatility of inorganic nanoparticles makes them very suitable as potential delivery carriers. However, the transfection efficiency of these

References (72)

  • S.Y. Kwak et al.

    Inorganic delivery vector for intravenous injection

    Biomaterials

    (2004)
  • D. Luo et al.

    A self-assembled, modular DNA delivery system mediated by silica nanoparticles

    Journal of Controlled Release

    (2004)
  • H. Nakayama et al.

    Intercalation of amino acids and peptides into Mg-Al-layered double hydroxide by reconstruction method

    International Journal of Pharmaceutical

    (2004)
  • J.M. Oh et al.

    The effect of synthetic conditions on tailoring the size of hydrotalcite particles

    Solid State Ionics

    (2002)
  • M.O. Oyewumi et al.

    Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice

    Journal of Controlled Release

    (2004)
  • M. Ozkan

    Quantum dots and other nanoparticles: what can they offer to drug delivery?

    Drug Discovery Today

    (2004)
  • C.W. Pouton et al.

    Key issues in non-viral gene delivery

    Advanced Drug Delivery Review

    (1998)
  • K.M. Tyner et al.

    Intercalation, delivery, and expression of the gene encoding green fluorescence protein utilizing nanobiohybrids

    Journal of Controlled Release

    (2004)
  • K.M. Tyner et al.

    Nanobiohybrids as delivery vehicles for camptothecin

    Journal of Controlled Release

    (2004)
  • K.J. Widder et al.

    Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin-total remission in Yoshida sarcoma-bearing rats

    European Journal of Cancer and Clinical Oncology

    (1983)
  • Y. Zhang et al.

    Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake

    Biomaterials

    (2002)
  • M.E. Akerman et al.

    Nanocrystal targeting in vivo

    Proceedings of the National Academy of Sciences of the United States of America

    (2002)
  • T. Azzam et al.

    Current development in gene transfection agents

    Current Drug Delivery

    (2004)
  • K. Balasubramanian et al.

    Chemically functonalized carbon nanotubes

    Small

    (2005)
  • C. Barbe et al.

    Silica particles: a novel drug-delivery system

    Advanced Materials

    (2004)
  • L.A. Bauer et al.

    Biological applications of high aspect ratio nanoparticles

    Journal of Materials Chemistry

    (2004)
  • C.C. Berry et al.

    Functionalization of magnetic nanoparticles for applications in biomedicine

    Journal of Physics D: Applied Physics

    (2003)
  • S. Bisht et al.

    pDNA loaded calcium phosphate nanoparticles: highly efficient non-viral vector for gene delivery

    International Journal of Pharmaceutics

    (2004)
  • Braterman, P.S., Xu, Z.P., Yarberry, F., 2004. Chemistry of layered double hydroxides, In: Auerbach, S.M., Carrado,...
  • Y. Chen et al.

    Sodium chloride modified silica nanoparticles as a non-viral vector with a high efficiency of DNA transfer into cells

    Current Gene Therapy

    (2003)
  • J.H. Choy et al.

    Intercalative nanohybrids of nucleotide monophosphates and DNA in layered metal hydroxide

    Journal of the American Chemical Society

    (1999)
  • J.H. Choy et al.

    Inorganic layered double hydroxides as nonviral vectors

    Angewandte Chemie, International Edition

    (2000)
  • J.H. Choy et al.

    Cellular uptake behavior of [γ-32P] labeled ATP-LDH nanohybrids

    Journal of Materials Chemistry

    (2001)
  • E.E. Connor et al.

    Gold nanoparticles are taken up by human cells but do not cause acute cytoxicity

    Small

    (2005)
  • M.C. Garnett

    Gene-delivery systems using cationic polymers

    Critical Reviews in Therapeutic Drug Carrier Systems

    (2004)
  • X. He et al.

    A novel DNA-enrichment technology based on amino-modified functionalised silica nanoparticles

    Journal of Dispersion Science and Technology

    (2003)
  • Cited by (0)

    View full text